Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

Osteoporosis medication 'doubles cancer risk'

  • Comment

People who take oral bisphosphonates for osteoporosis over five years may be doubling their risk of developing oesophageal cancer, according to a UK study published online in the BMJ.

Oxford University researchers analysed data on 2,954 men and women with oesophageal cancer, 2,018 with stomach cancer and 10,641 with colorectal cancer.

They found people with 10 or more bisphosphonate prescriptions over about five years had nearly double the risk of oesophageal cancer compared with people with none. There was no such increased risk for stomach or bowel cancer.

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.

Related Jobs